Skip to main content
BaxterRetirement

Hologic hires former Baxter leader José Almeida as CEO.

What happened

Almeida retired from Baxter as CEO on Feb 1st '25.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Hologic hires former Baxter leader José Almeida as CEO. The company appointed Almeida as chief executive in conjunction with the completion of an $18.3 billion go-private deal. Published April 8, 2026 Name: José Almeida New title: CEO, Hologic Previous title: CEO, Baxter Hologic has appointed José Almeida as CEO, putting the former Baxter leader in charge of the company as it starts life as a privately owned business. On Monday, Hologic said Steve MacMillan would retire as CEO once Blackstone and TPG closed their $18.3 billion deal to take the women's health company private. The investors completed the takeover Tuesday. In connection with closing the deal, Hologic revealed it has appointed Almeida as CEO with immediate effect. Almeida retired as Baxter CEO in February 2025. During Almeida's time as CEO, Baxter bought Hillrom for $10.5 billion and divested its biopharma solutions and kidney care businesses. The deals were part of an attempt to increase Baxter's focus on higher-growth markets. Hologic ended last year with $2.17 billion in cash and cash equivalents. At a meeting last year to discuss an offer to buy the business, Hologic's board said that the company had a "strong balance sheet to fund growth initiatives, such as innovation and acquisitions." The board also noted the underperformance of medtech stocks and the potential for investors' focus on short-term...

Keep reading with a free account

The rest of this article, and every signal for Baxter, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Retirement

What this signalsA successor often reviews the vendors the last leader chose.

Person
AlmeidaCEO
Takes effect
Feb 1, 2025

More retirement signals at other companies

The full record

From the Signal API record

People

  • AlmeidaCEO · Named in the story

Details

Category
Retires from

Topics and mentions

Job title tags

  • directors

Extraction

Confidence
46%
Detected
Apr 8, 2026
signal_type
news
signal_subtype
retires_from

Use this data

Get every retirement signal for Baxter and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Baxter this week?”

  2. Send it to your own tools

    The Signal API returns retirement signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/60f32d6f-01af-4835-8f16-59ed6c93821c returns this record as JSON. POST /v1/companies/enrich returns every signal for baxter.com.

{
  "signal_id": "60f32d6f-01af-4835-8f16-59ed6c93821c",
  "signal_type": "news",
  "signal_subtype": "retires_from",
  "detected_at": "2026-04-08T00:00:00+00:00",
  "company": {
    "name": "Baxter",
    "domain": "baxter.com"
  },
  "data": {
    "url": "https://www.medtechdive.com/news/hologic-hires-ex-baxter-leader-jose-almeida-as-ceo/816919",
    "title": "Hologic hires former Baxter leader José Almeida as CEO.",
    "contact": "Almeida",
    "excerpt": "Hologic hires former Baxter leader José Almeida as CEO.\n\nThe company appointed Almeida as chief executive in conjunction with the completion of an $18.3 billion go-private deal.\n\nPublished April 8, 2026\n\nName: José Almeida\n\nNew title: CEO, Hologic\n\nPrevious title: CEO, Baxter\n\nHologic has appointed José Almeida as CEO, putting the former Baxter leader in charge of the company as it starts life as a privately owned business.\n\nOn Monday, Hologic said Steve MacMillan would retire as CEO once Blackstone and TPG closed their $18.3 billion deal to take the women's health company private. The investors completed the takeover Tuesday. In connection with closing the deal, Hologic revealed it has appointed Almeida as CEO with immediate effect.\n\nAlmeida retired as Baxter CEO in February 2025. During Almeida's time as CEO, Baxter bought Hillrom for $10.5 billion and divested its biopharma solutions and kidney care businesses. The deals were part of an attempt to increase Baxter's focus on higher-growth markets.\n\nHologic ended last year with $2.17 billion in cash and cash equivalents. At a meeting last year to discuss an offer to buy the business, Hologic's board said that the company had a \"strong balance sheet to fund growth initiatives, such as innovation and acquisitions.\" The board also noted the underperformance of medtech stocks and the potential for investors' focus on short-term...",
    "summary": "Almeida retired from Baxter as CEO on Feb 1st '25.",
    "category": "retires_from",
    "found_at": "2026-04-08T00:00:00Z",
    "planning": false,
    "image_url": "https://imgproxy.divecdn.com/hPjhQT8BNtXFEIjy3tXm7sE9GmN1aBtFaMbnCsFavog/g:nowe:0:62/c:605:342/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CYXh0ZXJfSm9lX0FsbWVpZGFfbmV3ZXIuanBn.webp",
    "job_title": "CEO",
    "confidence": 0.462,
    "published_at": "2026-04-08T00:00:00Z",
    "effective_date": "2025-02-01",
    "job_title_tags": [
      "directors"
    ],
    "article_sentence": "Almeida retired as Baxter CEO in February 2025."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.